Comparison of aripiprazole augmentation versus bupropion combination for patient with major depressive disorder

被引：1

作者：

Lee, K. ^{[1
]}

Lee, J. B. ^{[2
]}

Park, Y. W. ^{[3
]}

Lee, J. H. ^{[4
]}

Lee, S. J. ^{[5
]}

Koo, B. H. ^{[5
]}

Sung, H. M. ^{[6
]}

Cheon, E. J. ^{[5
]}

机构：

[1] Dongguk Univ Hosp, Psychiat, Gyeongjy, South Korea

[2] Yeungnam Univ Hosp, Psychiat, Daegu, South Korea

[3] Fatima Hosp, Psychiat, Daegu, South Korea

[4] Catholic Univ Daegu Hosp, Psychiat, Daegu, South Korea

[5] Kyungpook Univ Hosp, Psychiat, Daegu, South Korea

[6] Cha Univ Hosp, Psychiat, Gumi, South Korea

来源：

EUROPEAN NEUROPSYCHOPHARMACOLOGY | 2014年 / 24卷

关键词：

D O I：

10.1016/S0924-977X(14)70724-2

中图分类号：

R74 [神经病学与精神病学];

学科分类号：

摘要：

P.2.f.003

引用

页码：S452 / S453

页数：2

共 50 条

[31] Aripiprazole-Induced Gray Matter Growth in a Patient With Major Depressive Disorder With Panic Disorder [J].

Lai, Chien-Han .

JOURNAL OF CLINICAL PSYCHIATRY, 2010, 71 (03) :360-362

[32] The Efficacy and Tolerability of Bupropion in the Treatment of Major Depressive Disorder [J].

Ricardo Moreira .

Clinical Drug Investigation, 2011, 31 :5-17

[33] The Efficacy and Tolerability of Bupropion in the Treatment of Major Depressive Disorder [J].

Moreira, Ricardo .

CLINICAL DRUG INVESTIGATION, 2011, 31 :5-17

[34] Bupropion in the treatment of outpatients with asthma and major depressive disorder [J].

Brown, E. Sherwood ;

Vornik, Lana A. ;

Khan, David A. ;

Rush, A. John .

INTERNATIONAL JOURNAL OF PSYCHIATRY IN MEDICINE, 2007, 37 (01) :23-28

[35] Bupropion for major depressive disorder: Pharmacokinetic and formulation considerations [J].

Jefferson, JW ;

Pradko, JF ;

Muir, KT .

CLINICAL THERAPEUTICS, 2005, 27 (11) :1685-1695

[36] Aripiprazole augmentation induced hypertension in depressive disorder: A case report [J].

Hsiao, Yi-Ling ;

Chen, Shaw-Ji ;

Shen, Tsu-Wang ;

Chang, Chun-Hung ;

Chen, Shao-Tsu .

PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY, 2011, 35 (01) :305-306

[37] An open pilot stud of the combination of escitalopram and bupropion-SR for outpatients with major depressive disorder [J].

Leuchter, Andrew F. ;

Lesser, Ira M. ;

Trivedi, Madhukar H. ;

Rush, A. John ;

Morris, David W. ;

Warden, Diane ;

Fava, Maurizio ;

Wisniewski, Stephen R. ;

Luther, James F. ;

Perales, Mercedes ;

Gaynes, Bradley N. ;

Stewart, Jonathan W. .

JOURNAL OF PSYCHIATRIC PRACTICE, 2008, 14 (05) :271-280

[38] Antidepressant for major depressive disorder. Comparison with vortioxetine, agomelatine, desvenlafaxine and bupropion XR [J].

Plasencia Garcia de Diego, B. O. ;

Romero Guillena, S. L. ;

Navarro Pablo, R. ;

Gotor Sanchez-Luengo, F. ;

Santamaria Gomez, O. .

EUROPEAN PSYCHIATRY, 2018, 48 :S205-S206

[39] The Choice of Either Quetiapine or Aripiprazole as Augmentation Treatment in a European Naturalistic Sample of Patients With Major Depressive Disorder [J].

Bartova, Lucie ;

Fugger, Gernot ;

Dold, Markus ;

Kautzky, Alexander ;

Swoboda, Marleen Margret Mignon ;

Rujescu, Dan ;

Zohar, Joseph ;

Souery, Daniel ;

Mendlewicz, Julien ;

Montgomery, Stuart ;

Fabbri, Chiara ;

Serretti, Alessandro ;

Kasper, Siegfried .

INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 2022, 25 (02) :118-127

[40] Aripiprazole as adjunctive therapy in patients with major depressive disorder [J].

Graber, Mark A. ;

Dachs, Robert ;

Darby-Stewart, Andrea .

AMERICAN FAMILY PHYSICIAN, 2008, 78 (03) :308-+

← 1 2 3 4 5 →